Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-4.43%
0%
-4.43%
6 Months
-6.73%
0%
-6.73%
1 Year
1.57%
0%
1.57%
2 Years
-35.76%
0%
-35.76%
3 Years
-47.57%
0%
-47.57%
4 Years
-61.68%
0%
-61.68%
5 Years
0%
0%
0.0%
Life Science Reit Plc for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
4.41%
EBIT Growth (5y)
2.38%
EBIT to Interest (avg)
1.48
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
4.23%
ROE (avg)
0.95%
Valuation key factors
Factor
Value
P/E Ratio
4
Industry P/E
Price to Book Value
0.55
EV to EBIT
23.88
EV to EBITDA
6.14
EV to Capital Employed
0.54
EV to Sales
1.82
PEG Ratio
0.03
Dividend Yield
NA
ROCE (Latest)
2.27%
ROE (Latest)
12.82%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bearish
Dow Theory
No Trend
Mildly Bearish
OBV
No Trend
Mildly Bullish
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'19 - YoY
Mar'19
Mar'18
Change(%)
Net Sales
30.40
12.90
135.66%
Operating Profit (PBDIT) excl Other Income
6.30
3.40
85.29%
Interest
2.20
1.00
120.00%
Exceptional Items
0.00
0.00
Consolidate Net Profit
5.30
3.30
60.61%
Operating Profit Margin (Excl OI)
0.00%
0.00%
NA
USD in Million.
Net Sales
YoY Growth in quarter ended Mar 2019 is 135.66% vs 0.00% in Mar 2018
Consolidated Net Profit
YoY Growth in quarter ended Mar 2019 is 60.61% vs 320.00% in Mar 2018
Annual Results Snapshot (Consolidated) - Dec'23
Dec'23
Dec'22
Change(%)
Net Sales
19.90
15.70
26.75%
Operating Profit (PBDIT) excl Other Income
8.70
6.30
38.10%
Interest
11.10
3.80
192.11%
Exceptional Items
-22.80
-31.30
27.16%
Consolidate Net Profit
-21.70
-27.60
21.38%
Operating Profit Margin (Excl OI)
437.40%
399.40%
3.80%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2023 is 26.75% vs 3,040.00% in Dec 2022
Consolidated Net Profit
YoY Growth in year ended Dec 2023 is 21.38% vs -458.44% in Dec 2022
About Life Science Reit Plc 
Life Science Reit Plc
Realty
No Details Available.
Company Coordinates 
No Company Details Available






